Vilnius-based medtech startup OxipitAI has collected €3.5 million from VC fund Taiwania Capital. The startup creates AI tools for global medical imaging. The funding will help the company accelerate its growth and welcome new teammates and customers. In 2019, the startup secured €1.7M in seed funding from Practica Capital, Koinvesticinis fund and angel investors which was the largest investment for medical AI solutions in the Baltic states at that time. Oxipit is targeting to raise an additional €4.8 million from its existing investors in the near future.
Oxipit was founded in 2017 by a team of 6 scientists coming from diverse academic backgrounds. The team features multiple-time Kaggle competition winners, as well as members with a proven track record in leading global AI and data science applications.
Oxipit is a computer vision software startup specialising in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice.
Oxipit is the author of ChestEye AI-powered radiology software suite. Automated AI-based diagnosis and reporting by ChestEye enable radiologists to improve productivity, reduce error rate, discover overlooked secondary findings and address the shortage and ever-increasing workload of radiology specialists.
Click to read more funding news.
